2019
DOI: 10.1007/s10096-019-03714-9
|View full text |Cite
|
Sign up to set email alerts
|

Patterns of antimicrobial consumption in neonatal and pediatric intensive care units in Germany and Brazil

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
10
2

Year Published

2020
2020
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 12 publications
(14 citation statements)
references
References 15 publications
2
10
2
Order By: Relevance
“…A similar observation was also reported by Al-Turkait et al [24]. Because neonatal sepsis could negatively impact mortality, many physicians are sometimes hesitant to discontinue antibiotic administration despite improvement in infection symptoms or clinical appearance [24,25].…”
Section: Discussionsupporting
confidence: 67%
“…A similar observation was also reported by Al-Turkait et al [24]. Because neonatal sepsis could negatively impact mortality, many physicians are sometimes hesitant to discontinue antibiotic administration despite improvement in infection symptoms or clinical appearance [24,25].…”
Section: Discussionsupporting
confidence: 67%
“…The studies were conducted in 26 countries ( Figure 2) with India and the United States of America (USA) accounting for the largest number of reports, 14 and 13 respectively. There was one study that involved several European countries (21 participated) [65] and one study conducted in Germany and Brazil [66]. drugs received by infants born at 22-24 weeks gestational age only.…”
Section: Characteristics Of Included Studiesmentioning
confidence: 99%
“…Glycopeptide use among PICUs (98 DOT/1000pd) was more than three-times higher than glycopeptide use among non-ICU wards (30 DOT/1000pd); this is likely due in part to more frequent use of central lines and coverage for coagulase negative staphylococci on PICUs. Glycopeptide use among PICUs in this study was similar to use on a German PICU (90 DOT/1000pd) [ 56 ], but lower than Brazilian, Saudi Arabian and South African PICUs (151 to 263 DOT/1000pd) [ 52 , 54 56 ]. Differences in glycopeptide use may be partially due to differences in rates of methicillin-resistant Staphylococcus aureus across jurisdictions [ 56 ].…”
Section: Discussionmentioning
confidence: 69%
“…A 2015 study of AMU among a PICU in South Africa reported a rate of 1336 DOT/1000pd [ 52 ]. A study of German and Brazilian PICUs found rates of 888 and 1441 DOT/1000pd, respectively; patients with < 24 h of AMU were excluded in this study [ 56 ].…”
Section: Discussionmentioning
confidence: 99%